Novel Materials for Cancer Diagnostics and Treatment
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Cancer Therapies".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 79
Special Issue Editors
Interests: control, design and synthesis of nanomaterials; nanomedicine; nanotoxicology
Interests: cancer nanomedicine; infant respiratory diseases—mainly bronchopulmonary dysplasia; drug delivery systems; preclinical imaging (stronger focus on optical imaging); in vitro toxicology
Special Issue Information
Dear Colleagues,
Cancer is one of the deadliest diseases in the world today, posing a great threat to human life and health. Traditional treatments such as surgery, chemotherapy, and radiotherapy are key strategies for treating solid tumors, but these methods have limitations, including unavoidable side effects and difficulty in eradicating tumors. Clinical medicine urgently needs to develop novel treatment models to improve the efficiency of cancer treatment and relieve patients' suffering.
Fortunately, the properties of engineered nanomaterials can be precisely tuned by controlling their size, shape, synthesis conditions, and functionalization. Recently, engineered nanomaterial-based nanotheranostics have received widespread attention in the field of nanomedicine in applications such as drug delivery, sonodynamic therapy (SDT), photothermal therapy (PTT), and photodynamic therapy (PDT). However, there are still challenges such as unclear mechanism of action, low targeting efficiency, and poor biocompatibility. Therefore, the development of new low-toxicity nanotargeted drugs has become an urgent need.
This Special Issue (‘Novel Materials for Cancer Diagnostics and Treatment’) seeks to publish creative works that help to improve this situation. These studies should focus on the scope of the rational design of nanomaterials, bioimaging, targeted delivery drug systems, and non-invasive or minimally invasive treatment methods for cancer.
We look forward to receiving your submissions and working with you.
Dr. Shunhao Wang
Dr. Bella Manshian
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- novel nanomaterials for biomedical applications
- nanocarriers
- precision cancer imaging
- targeted therapy
